SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 20.24%335.52M | 10.27%363.22M | 97.83%435.74M | 2.48%265.71M | 2.48%265.71M | -3.48%279.04M | 1.18%329.4M | 15.29%220.26M | 18.02%259.28M | 18.02%259.28M |
-Cash and cash equivalents | 11.79%97.05M | -58.84%88.22M | 34.29%215.8M | -61.95%53.23M | -61.95%53.23M | -38.24%86.81M | -34.17%214.32M | -15.89%160.7M | -36.32%139.89M | -36.32%139.89M |
-Short-term investments | 24.06%238.47M | 138.96%275M | 269.24%219.94M | 77.97%212.48M | 77.97%212.48M | 29.43%192.23M | --115.08M | --59.57M | --119.39M | --119.39M |
Restricted cash | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --1.26M | --1.26M | --1.26M |
Other current assets | -13.06%6.01M | 31.93%6.76M | 29.72%6.16M | 14.11%5.06M | 14.11%5.06M | 13.91%6.91M | 32.71%5.12M | 28.89%4.75M | 50.39%4.44M | 50.39%4.44M |
Total current assets | 19.44%341.53M | 10.60%369.97M | 95.30%441.9M | 2.19%270.77M | 2.19%270.77M | -3.53%285.95M | 1.16%334.52M | 16.19%226.27M | 19.01%264.97M | 19.01%264.97M |
Non current assets | ||||||||||
Net PPE | -10.51%27.6M | -9.98%28.41M | -8.73%29.35M | -2.43%30.34M | -2.43%30.34M | 1.52%30.84M | 3.55%31.56M | 509.54%32.15M | 594.64%31.1M | 594.64%31.1M |
-Gross PPE | -10.51%27.6M | -9.98%28.41M | -8.73%29.35M | 4.64%34.01M | 4.64%34.01M | 1.52%30.84M | 3.55%31.56M | 509.54%32.15M | 545.35%32.5M | 545.35%32.5M |
-Accumulated depreciation | ---- | ---- | ---- | -161.60%-3.67M | -161.60%-3.67M | ---- | ---- | ---- | -150.63%-1.4M | -150.63%-1.4M |
Investments and advances | -70.32%10.03M | 24.06%26.69M | --0 | --7.46M | --7.46M | --33.79M | --21.51M | ---- | --0 | --0 |
Other non current assets | 0.00%4.86M | 1.82%4.86M | 1.82%4.86M | 2.51%4.86M | 2.51%4.86M | 1.97%4.86M | -2.45%4.78M | -30.40%4.78M | -4.76%4.75M | -4.76%4.75M |
Total non current assets | -38.86%42.49M | 3.65%59.96M | -7.37%34.21M | 19.03%42.67M | 19.03%42.67M | 97.74%69.49M | 63.52%57.85M | 204.28%36.93M | 278.94%35.84M | 278.94%35.84M |
Total assets | 8.04%384.02M | 9.57%429.94M | 80.89%476.11M | 4.20%313.44M | 4.20%313.44M | 7.20%355.45M | 7.19%392.37M | 27.23%263.2M | 29.61%300.81M | 29.61%300.81M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 52.62%15.06M | 25.33%8.98M | 273.08%15.57M | 82.39%10.66M | 82.39%10.66M | 141.09%9.87M | 105.07%7.16M | 3.91%4.17M | 67.73%5.84M | 67.73%5.84M |
-accounts payable | 52.62%15.06M | 25.33%8.98M | 273.08%15.57M | 82.39%10.66M | 82.39%10.66M | 141.09%9.87M | 105.07%7.16M | 3.91%4.17M | 67.73%5.84M | 67.73%5.84M |
Current accrued expenses | 65.50%28.43M | 94.19%23.63M | 29.75%16.62M | 38.50%15.81M | 38.50%15.81M | 88.43%17.18M | 66.04%12.17M | 91.12%12.81M | 148.95%11.42M | 148.95%11.42M |
Current debt and capital lease obligation | 13.10%1.52M | 25.32%1.48M | 51.21%1.43M | -2.60%1.39M | -2.60%1.39M | -33.27%1.34M | -87.00%1.18M | -60.46%947K | -38.77%1.42M | -38.77%1.42M |
-Current capital lease obligation | 13.10%1.52M | 25.32%1.48M | 51.21%1.43M | -2.60%1.39M | -2.60%1.39M | -33.27%1.34M | -87.00%1.18M | -60.46%947K | -38.77%1.42M | -38.77%1.42M |
Other current liabilities | -33.19%306K | -49.19%252K | -37.34%636K | -79.04%441K | -79.04%441K | -89.24%458K | -89.27%496K | 302.78%1.02M | 795.32%2.1M | 795.32%2.1M |
Current liabilities | 52.79%53.05M | 55.31%40M | 73.70%36.69M | 42.16%38.17M | 42.16%38.17M | 47.42%34.72M | -6.87%25.76M | 18.13%21.12M | 57.22%26.85M | 57.22%26.85M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -8.53%16.31M | -8.11%16.71M | -7.69%17.09M | -4.16%17.47M | -4.16%17.47M | -1.32%17.83M | -4.34%18.18M | 1,542.86%18.52M | 2,093.26%18.23M | 2,093.26%18.23M |
-Long term capital lease obligation | -8.53%16.31M | -8.11%16.71M | -7.69%17.09M | -4.16%17.47M | -4.16%17.47M | -1.32%17.83M | -4.34%18.18M | 1,542.86%18.52M | 2,093.26%18.23M | 2,093.26%18.23M |
Total non current liabilities | -8.53%16.31M | -8.11%16.71M | -7.69%17.09M | -4.16%17.47M | -4.16%17.47M | -1.32%17.83M | -4.34%18.18M | 1,542.86%18.52M | 2,093.26%18.23M | 2,093.26%18.23M |
Total liabilities | 31.99%69.36M | 29.06%56.71M | 35.68%53.78M | 23.43%55.64M | 23.43%55.64M | 26.26%52.55M | -5.84%43.94M | 108.54%39.64M | 151.70%45.08M | 151.70%45.08M |
Shareholders'equity | ||||||||||
Share capital | 84.15%110.71M | 83.07%114.23M | 256.28%222.25M | -8.77%60.12M | -8.77%60.12M | -8.77%60.12M | -12.69%62.4M | -20.48%62.38M | -22.87%65.9M | -22.87%65.9M |
-common stock | 27.91%110K | 28.24%109K | 35.21%96K | 22.86%86K | 22.86%86K | 22.86%86K | 28.79%85K | 54.35%71K | 59.09%70K | 59.09%70K |
-Preferred stock | 84.23%110.6M | 83.15%114.12M | 256.53%222.15M | -8.80%60.04M | -8.80%60.04M | -8.80%60.04M | -12.73%62.31M | -20.52%62.31M | -22.92%65.83M | -22.92%65.83M |
Retained earnings | -44.11%-791.56M | -45.97%-720.92M | -47.17%-661.97M | -46.79%-603.62M | -46.79%-603.62M | -47.81%-549.26M | -46.75%-493.88M | -49.13%-449.8M | -51.75%-411.21M | -51.75%-411.21M |
Paid-in capital | 25.55%994.61M | 25.65%980.11M | 41.10%862.1M | 33.25%801.06M | 33.25%801.06M | 32.97%792.21M | 33.46%780.01M | 48.65%610.97M | 50.40%601.15M | 50.40%601.15M |
Gains losses not affecting retained earnings | 620.93%896K | -97.94%-192K | -343.75%-39K | 336.54%246K | 336.54%246K | -5.52%-172K | ---97K | --16K | ---104K | ---104K |
Total stockholders'equity | 3.88%314.66M | 7.12%373.22M | 88.91%422.33M | 0.81%257.8M | 0.81%257.8M | 4.47%302.9M | 9.09%348.43M | 19.00%223.56M | 19.40%255.74M | 19.40%255.74M |
Total equity | 3.88%314.66M | 7.12%373.22M | 88.91%422.33M | 0.81%257.8M | 0.81%257.8M | 4.47%302.9M | 9.09%348.43M | 19.00%223.56M | 19.40%255.74M | 19.40%255.74M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |